<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK547946" /><meta name="ncbi_domain" content="livertox" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK547946/" /><meta name="ncbi_pagename" content="Clopidogrel - LiverTox - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Clopidogrel - LiverTox - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]" /><meta name="citation_title" content="Clopidogrel" /><meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="citation_date" content="2017/10/17" /><meta name="citation_pmid" content="31643279" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK547946/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Clopidogrel" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="DC.Date" content="2017/10/17" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK547946/" /><meta name="description" content="Clopidogrel is an inhibitor of platelet aggregation that is used to decrease the risk of myocardial infarction and stroke in patients known to have atherosclerosis. Clopidogrel has been linked to rare instances of idiosyncratic, clinically apparent acute liver injury." /><meta name="og:title" content="Clopidogrel" /><meta name="og:type" content="book" /><meta name="og:description" content="Clopidogrel is an inhibitor of platelet aggregation that is used to decrease the risk of myocardial infarction and stroke in patients known to have atherosclerosis. Clopidogrel has been linked to rare instances of idiosyncratic, clinically apparent acute liver injury." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK547946/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/livertox/Clopidogrel/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK547946/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D1B74046641D100000000056401AD.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All Drug Records" href="/books/n/livertox/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" alt="Cover of LiverTox" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK547946_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK547946_dtls__"><div>Bethesda (MD): <a href="https://www.niddk.nih.gov/" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">National Institute of Diabetes and Digestive and Kidney Diseases</a>; 2012-.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/livertox/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search this book" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search this book" submit="false" style="padding: 0.1em 0.4em;" /></div></form></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Clonidine/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Clorazepate/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK547946_"><span class="title" itemprop="name">Clopidogrel</span></h1><p class="small">Last Update: <span itemprop="dateModified">October 17, 2017</span>.</p></div><div class="body-content whole_rhythm" itemprop="text"><div id="Clopidogrel.OVERVIEW"><h2 id="_Clopidogrel_OVERVIEW_">OVERVIEW</h2><div id="Clopidogrel.Introduction"><h3>Introduction</h3><p>Clopidogrel is an inhibitor of platelet aggregation that is used to decrease the risk of myocardial infarction and stroke in patients known to have atherosclerosis. Clopidogrel has been linked to rare instances of idiosyncratic, clinically apparent acute liver injury.</p></div><div id="Clopidogrel.Background"><h3>Background</h3><p>Clopidogrel (kloe pid' oh grel) is an inhibitor of adenosine diphosphate (ADP)-induced platelet aggregation and is used widely to decrease the risk of myocardial infarction and stoke in patients who have documented coronary or cerebrovascular disease or previous heart attack or stroke. Activated platelets release ADP which binds to platelet receptors, causing activation of intracellular glycoprotein IIb/IIIA complex which triggers platelet adherence and aggregation. The aggregation of platelets plays an important role in the growth of atheromatous plaques, which can lead to coronary, cerebral and peripheral arterial occlusions. In large clinical trials, clopidogrel therapy has been shown to decrease the frequency of recurrence of myocardial infarction and stroke. Clopidogrel was approved for use in the United States in 1997 and is widely used, with more than 1.5 million prescriptions filled yearly. Current indications include reduction of atherosclerotic events (myocardial infarction, stroke, vascular death) in patients with documented atherosclerosis and in patients with acute myocardial infarction or unstable angina. Clopidogrel is available in 75 mg tablets generically and under the brand name of Plavix. The usual dose is 75 mg daily, sometimes with a loading dose of 300 mg on day one. Side effects are not common, but can include headache, dizziness, fatigue, gastrointestinal upset, nausea, arthralgias and rash.</p></div><div id="Clopidogrel.Hepatotoxicity"><h3>Hepatotoxicity</h3><p>Clopidogrel is associated with serum enzyme elevations in 1% to 3% of patients during therapy. In several large clinical trials, elevations of serum <a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> were no more frequent with clopidogrel as with placebo (or in comparator arms) and no instances of clinically apparent liver injury were reported. Since marketing and release, however, there have been more than a dozen published case reports of clinically apparent liver injury attributed to clopidogrel. The onset of symptoms was within 2 to 24 weeks (averaging 6 weeks) of starting, with fatigue and jaundice. Several patients had an accompanying fever but rash and eosinophilia were not common. The usual pattern of liver enzyme elevations was hepatocellular, but cases with mixed or cholestatic enzyme elevations have also been described (Case 1). <a class="def" href="/books/n/livertox/glossary/def-item/glossary.autoantibodies/">Autoantibodies</a> were rarely present. Most cases were self-limited with recovery within 1 to 2 months, but rare cases of acute liver failure or hepatic decompensation with death or need for liver transplantation have been described.</p><p>Likelihood score: B (highly likely but rare cause of clinically apparent liver injury).</p></div><div id="Clopidogrel.Mechanism_of_Injury"><h3>Mechanism of Injury</h3><p>The mechanism of clopidogrel hepatotoxicity is not known, but is clearly idiosyncratic and may be due to the complex hepatic metabolism of the clopidogrel molecule. Immunoallergic features are usually not prominent, but hypersensitivity reactions to clopidogrel have been described. The effectiveness of clopidogrel is dependent upon its activation in the liver by CYP 2C19 and poor metabolizers of this enzyme may not respond adequately to its antiplatelet activity. Furthermore, it is susceptible to drug-drug interactions with agents that induce or inhibit CYP 2C19.</p></div><div id="Clopidogrel.Outcome_and_Management"><h3>Outcome and Management</h3><p>The severity of liver injury associated with clopidogrel ranges from transient, mild serum enzyme elevations to clinically apparent acute hepatitis that can be severe and lead to death. Most cases resolve with drug withdrawal within 1 to 3 months. <a class="def" href="/books/n/livertox/glossary/def-item/glossary.rechallenge/">Rechallenge</a> with clopidogrel usually results in recurrence of liver injury and should be avoided. However, there does not appear to be cross sensitivity to the liver injury between clopidogrel and ticlopidine or dipyridamole.</p><p>Drug Class: <a href="/books/n/livertox/Anticoagulants/">Antithrombotic Agents</a>, <a href="/books/n/livertox/Anticoagulants/">Antiplatelet Agents</a></p><p>Other Drugs in the Subclass, Antiplatelet Agents: <a href="/books/n/livertox/Aspirin/">Aspirin</a>, <a href="/books/n/livertox/Cangrelor/">Cangrelor</a>, <a href="/books/n/livertox/Dipyridamole/">Dipyridamole</a>, <a href="/books/n/livertox/Prasugrel/">Prasugrel</a>, <a href="/books/n/livertox/Ticagrelor/">Ticagrelor</a>, <a href="/books/n/livertox/Ticlopidine/">Ticlopidine</a>, <a href="/books/n/livertox/Vorapaxar/">Vorapaxar</a></p></div></div><div id="Clopidogrel.CASE_REPORT"><h2 id="_Clopidogrel_CASE_REPORT_">CASE REPORT</h2><div id="Clopidogrel.Case_1._Acute_cholestatic_he"><h3>Case 1. Acute cholestatic hepatitis due to clopidogrel.</h3><p>[Modified from: Chau TN, Yim KF, Mok NS, Chan WK, Leung VK, Leung MF, Lai ST. Clopidogrel-induced hepatotoxicity after percutaneous coronary stenting. Hong Kong Med J 2005; 11: 414-6. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16219965" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>]</p><p>A 74 year old man with a history of hypertension and ischemic heart disease presented with retrosternal chest pain and underwent cardiac catheterization which showed complete occlusion of the left anterior descending and 80% occlusion of the left circumflex artery for which he underwent successful percutaneous stenting. Clopidogrel was started in preparation of the coronary artery stenting and continued after discharge. Four weeks later and 41 days after starting clopidogrel he developed dark urine and jaundice. He had no previous history of liver disease, drug allergies, alcohol abuse, or risk factors for viral hepatitis. Other medications included aspirin, isosorbide dinitrate and metoprolol, all of which had been taken for several years. Laboratory testing showed a serum bilirubin of 5.3 mg/dL, <a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> 212 U/L and alkaline phosphatase 172 U/L (Table). Serum albumin concentrations and prothrombin time were normal. Tests for acute hepatitis A, B, C (including HCV RNA) and E were negative as were smooth muscle and antinuclear antibodies. Abdominal ultrasound showed no hepatic masses or evidence of biliary obstruction. Four days after onset of jaundice, clopidogrel was stopped, while other medications were continued. Liver tests worsened for the first few days after presentation, but then began to improve and were within the normal range 3 months later.</p><div id="Clopidogrel.Key_Points"><h4>Key Points</h4><div id="Clopidogrel.T1" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547946/table/Clopidogrel.T1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Clopidogrel.T1_lrgtbl__"><table><thead><tr><th id="hd_h_Clopidogrel.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Medication:</th><td rowspan="1" colspan="1" style="vertical-align:top;">Clopidogrel (75 mg daily for 41 days)</td></tr></thead><tbody><tr><th headers="hd_h_Clopidogrel.T1_1_1_1_1" id="hd_b_Clopidogrel.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Pattern:</th><td headers="hd_b_Clopidogrel.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Mixed (R=3.5)</td></tr><tr><th headers="hd_h_Clopidogrel.T1_1_1_1_1" id="hd_b_Clopidogrel.T1_1_1_2_1" rowspan="1" colspan="1" style="vertical-align:top;">Severity:</th><td headers="hd_b_Clopidogrel.T1_1_1_2_1" rowspan="1" colspan="1" style="vertical-align:top;">3+ (jaundice, hospitalization)</td></tr><tr><th headers="hd_h_Clopidogrel.T1_1_1_1_1" id="hd_b_Clopidogrel.T1_1_1_3_1" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.latency/">Latency</a>:</th><td headers="hd_b_Clopidogrel.T1_1_1_3_1" rowspan="1" colspan="1" style="vertical-align:top;">41 days</td></tr><tr><th headers="hd_h_Clopidogrel.T1_1_1_1_1" id="hd_b_Clopidogrel.T1_1_1_4_1" rowspan="1" colspan="1" style="vertical-align:top;">Recovery:</th><td headers="hd_b_Clopidogrel.T1_1_1_4_1" rowspan="1" colspan="1" style="vertical-align:top;">3 months</td></tr><tr><th headers="hd_h_Clopidogrel.T1_1_1_1_1" id="hd_b_Clopidogrel.T1_1_1_5_1" rowspan="1" colspan="1" style="vertical-align:top;">Other medications:</th><td headers="hd_b_Clopidogrel.T1_1_1_5_1" rowspan="1" colspan="1" style="vertical-align:top;">Aspirin, isosorbide dinitrate, metoprolol</td></tr></tbody></table></div></div></div><div id="Clopidogrel.Laboratory_Values"><h4>Laboratory Values</h4><div id="Clopidogrel.T2" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547946/table/Clopidogrel.T2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Clopidogrel.T2_lrgtbl__"><table><thead><tr><th id="hd_h_Clopidogrel.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Time After Starting</th><th id="hd_h_Clopidogrel.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Time After Stopping</th><th id="hd_h_Clopidogrel.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a>* (U/L)</th><th id="hd_h_Clopidogrel.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Alk P* (U/L)</th><th id="hd_h_Clopidogrel.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.bilirubin/">Bilirubin</a>* (mg/dL)</th><th id="hd_h_Clopidogrel.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Other</th></tr></thead><tbody><tr><td headers="hd_h_Clopidogrel.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">1 day</td><td headers="hd_h_Clopidogrel.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Clopidogrel.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">30</td><td headers="hd_h_Clopidogrel.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">65</td><td headers="hd_h_Clopidogrel.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.5</td><td headers="hd_h_Clopidogrel.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Clopidogrel started</td></tr><tr><td headers="hd_h_Clopidogrel.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">1 week</td><td headers="hd_h_Clopidogrel.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Clopidogrel.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">25</td><td headers="hd_h_Clopidogrel.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">75</td><td headers="hd_h_Clopidogrel.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.5</td><td headers="hd_h_Clopidogrel.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Cardiac catheterization</td></tr><tr><td headers="hd_h_Clopidogrel.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">2 weeks</td><td headers="hd_h_Clopidogrel.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Clopidogrel.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">25</td><td headers="hd_h_Clopidogrel.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">70</td><td headers="hd_h_Clopidogrel.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.4</td><td headers="hd_h_Clopidogrel.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Clopidogrel.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">6 weeks</td><td headers="hd_h_Clopidogrel.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Clopidogrel.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">212</td><td headers="hd_h_Clopidogrel.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">172</td><td headers="hd_h_Clopidogrel.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">5.3</td><td headers="hd_h_Clopidogrel.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Clopidogrel stopped</td></tr><tr><td headers="hd_h_Clopidogrel.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Clopidogrel.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">2 days</td><td headers="hd_h_Clopidogrel.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">253</td><td headers="hd_h_Clopidogrel.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">202</td><td headers="hd_h_Clopidogrel.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">5.8</td><td headers="hd_h_Clopidogrel.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Clopidogrel.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Clopidogrel.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">3 days</td><td headers="hd_h_Clopidogrel.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">205</td><td headers="hd_h_Clopidogrel.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">185</td><td headers="hd_h_Clopidogrel.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">3.6</td><td headers="hd_h_Clopidogrel.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Clopidogrel.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">7 weeks</td><td headers="hd_h_Clopidogrel.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">5 days</td><td headers="hd_h_Clopidogrel.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">140</td><td headers="hd_h_Clopidogrel.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">155</td><td headers="hd_h_Clopidogrel.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">2.0</td><td headers="hd_h_Clopidogrel.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Clopidogrel.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">10 weeks</td><td headers="hd_h_Clopidogrel.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">1 month</td><td headers="hd_h_Clopidogrel.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">86</td><td headers="hd_h_Clopidogrel.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">110</td><td headers="hd_h_Clopidogrel.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.4</td><td headers="hd_h_Clopidogrel.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Clopidogrel.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">17 weeks</td><td headers="hd_h_Clopidogrel.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">3 months</td><td headers="hd_h_Clopidogrel.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">25</td><td headers="hd_h_Clopidogrel.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">90</td><td headers="hd_h_Clopidogrel.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.4</td><td headers="hd_h_Clopidogrel.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Clopidogrel.T2_1_1_1_1 hd_h_Clopidogrel.T2_1_1_1_2" colspan="2" rowspan="1" style="vertical-align:top;"><b>Normal Values</b></td><td headers="hd_h_Clopidogrel.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;40</b></td><td headers="hd_h_Clopidogrel.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;115</b></td><td headers="hd_h_Clopidogrel.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;1.2</b></td><td headers="hd_h_Clopidogrel.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div></div><p>* Some values estimated from figure.</p></div><div id="Clopidogrel.Comment"><h4>Comment</h4><p>A typical example of an acute liver injury with jaundice attributed to clopidogrel. Typical were the time of onset (4-5 weeks), the mixed pattern of serum enzyme elevations and the mild self-limited nature of the injury, with improvement starting within a week of stopping the medication. While the liver injury from clopidogrel resembles that of ticlopidine, there are some differences. Both agents are associated with acute liver injury that usually arises within 1 to 12 weeks of starting. However, the injury tends to be more hepatocellular with clopidogrel and the time to recovery slightly shorter. Interestingly, there does not seem to be cross sensitivity to hepatic injury between clopidogrel and ticlopidine, despite their similar chemical structures and mechanisms of action.</p></div></div></div><div id="Clopidogrel.PRODUCT_INFORMATION"><h2 id="_Clopidogrel_PRODUCT_INFORMATION_">PRODUCT INFORMATION</h2><div id="Clopidogrel.BPI" class="box"><p><b>REPRESENTATIVE TRADE NAMES</b></p><p>Clopidogrel &#x02013; Generic, Plavix&#x000ae;</p><p><b>DRUG CLASS</b></p><p>Antithrombotic Agents</p><p><a href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&#x00026;query=Clopidogrel" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COMPLETE LABELING</a></p><p>Product labeling at DailyMed, National Library of Medicine, NIH</p></div></div><div id="Clopidogrel.CHEMICAL_FORMULA_AND_STRUCTU"><h2 id="_Clopidogrel_CHEMICAL_FORMULA_AND_STRUCTU_">CHEMICAL FORMULA AND STRUCTURE</h2><div id="Clopidogrel.T3" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547946/table/Clopidogrel.T3/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Clopidogrel.T3_lrgtbl__"><table><thead><tr><th id="hd_h_Clopidogrel.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">DRUG</th><th id="hd_h_Clopidogrel.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">CAS REGISTRY NUMBER</th><th id="hd_h_Clopidogrel.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">MOLECULAR FORMULA</th><th id="hd_h_Clopidogrel.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">STRUCTURE</th></tr></thead><tbody><tr><td headers="hd_h_Clopidogrel.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Clopidogrel</td><td headers="hd_h_Clopidogrel.T3_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/135032924" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">90055-48-4</a></td><td headers="hd_h_Clopidogrel.T3_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C16-H16-Cl-N-O2-S</td><td headers="hd_h_Clopidogrel.T3_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK547946/bin/Clopidogrel_Structure.jpg" alt="Clopidogrel Chemical Structure" /></div></td></tr></tbody></table></div></div></div><div id="Clopidogrel.ANNOTATED_BIBLIOGRAPHY"><h2 id="_Clopidogrel_ANNOTATED_BIBLIOGRAPHY_">ANNOTATED BIBLIOGRAPHY</h2><p>References updated: 17 October 2017</p><ul class="first-line-outdent"><li><div class="bk_ref" id="Clopidogrel.R1">Zimmerman HJ. Platelet aggregation inhibitors. Drugs used in cardiovascular disease. In, Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott, 1999, pp. 641-3.<div><i>(Textbook of hepatotoxicity published in 1999 discusses ticlopidine, but not clopidogrel).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R2">De Marzio DH, Navarro VJ. Hepatotoxicity of cardiovascular and antidiabetic drugs: antihypertensives. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd ed. Amsterdam: Elsevier, 2013, p. 528.<div><i>(Review of hepatotoxicity of antiplatelet drugs mentions that clopidogrel like ticlopidine can cause liver injury although less commonly, and some patients with ticlopidine liver injury can tolerate clopidogrel without recurrence).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R3">Weitz JI. Blood coagulation and anticoagulant, fibrinolytic, and antiplatelet drugs. In, Brunton LL, Chabner BA, Knollman BC, eds. Goodman &#x00026; Gilman's the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill, 2011, pp. 849-76.<div><i>(Textbook of pharmacology and therapeutics).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R4">A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996; 348: 1329-39.  [<a href="/pubmed/8918275" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8918275</span></a>]<div><i>(Among 19,185 patients treated with either aspirin or clopidogrel and followed for an average of 1.9 years, abnormal liver tests were reported in 3% on clopidogrel vs 3.2% on aspirin and were severe in 0.5% vs 0.7%).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R5">Zeolla MM, Carson JJ. Successful use of clopidogrel for cerebrovascular accident in a patient with suspected ticlopidine-induced hepatotoxicity. Ann Pharmacoth 1999; 33: 939-41.  [<a href="/pubmed/10492495" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10492495</span></a>]<div><i>(79 year old woman developed elevations in serum enzymes 5 weeks after starting ticlopidine [bilirubin 0.3 mg/dL, ALT 1008 U/L, Alk P 648 U/L] without jaundice or symptoms, and levels fell to near normal within 20 days of switching to clopidogrel and were completely normal 4 months later).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R6">Jarvis B, Simpson K. Clopidogrel: a review of its use in the prevention of atherothrombosis. Drugs 2000; 60: 347-77.  [<a href="/pubmed/10983738" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10983738</span></a>]<div><i>(Review of the mechanism of action, pharmacokinetics, efficacy and safety of clopidogrel; side effects are slightly less common with clopidogrel than aspirin, serum enzyme elevations occurring in 3% vs 3.2% [CAPRIE]).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R7">Willens HJ. Clopidogrel-induced mixed hepatocellular and cholestatic liver injury. Am J Ther 2000; 7: 317-8.  [<a href="/pubmed/11317178" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11317178</span></a>]<div><i>(81 year old woman developed fatigue and anorexia 2 weeks and jaundice 4 weeks after starting clopidogrel [bilirubin 3.0 mg/dL, ALT 507 U/L, Alk P 636 U/L], resolving within 2 months of stopping).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R8">Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, Lenoir C, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002; 36: 451-5.  [<a href="/pubmed/12143055" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12143055</span></a>]<div><i>(Among 34 cases of drug induced liver injury identified in a population based survey in France [1997-2000], 1 case was attributed to clopidogrel, occurring in a 75 year old woman [bilirubin 6.6 mg/dL, ALT 8 times ULN, Alk P 2 times ULN], resolving within 1 month).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R9">Dur&#x000e1;n Quintana JA, Jim&#x000e9;nez S&#x000e1;enz M, Montero AR, Guti&#x000e9;rrez MH. [Clopidogrel probably induced hepatic toxicity]. Med Clin (Barc) 2002; 119: 37. Spanish.  [<a href="/pubmed/12062007" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12062007</span></a>]<div><i>(77 year old man developed jaundice 6 months after starting clopidogrel [bilirubin 13 mg/dL, ALT 786 U/L, Alk P 474 U/L], resolving within 4 months of stopping).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R10">Ramos Ramos JC, Sanz Moreno J, Calvo Carrasco L, Garc&#x000ed;a D&#x000ed;az Jde D. [Clopidogrel-induced hepatotoxicity]. Med Clin (Barc) 2003; 120: 156-7. Spanish.  [<a href="/pubmed/12605844" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12605844</span></a>]<div><i>(89 year old woman developed jaundice 8 weeks after starting clopidogrel [bilirubin 24.9 rising to 33.8 mg/dL, ALT 720 U/L, Alk P 118 U/L], resolving within 5 months of stopping).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R11">Wolf I, Mouallem M, Rath S, Farfel Z. Clopidogrel-induced systemic inflammatory response syndrome. Mayo Clin Proc 2003; 78: 618-20.  [<a href="/pubmed/12744550" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12744550</span></a>]<div><i>(50 year old woman developed fever, weakness and rash 2 weeks after starting clopidogrel [bilirubin 1.3 mg/dL, ALT 149 U/L, Alk P 132 U/L], resolving rapidly upon stopping and with positive rechallenge [fever and tachycardia within 4 hours]).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R12">Batwa F, Lamoureaux E, Friedman G. Clopidogrel-induced liver injury [case report]. Can J Gastroenterol 2003; 17: 232. Not in PubMed.<div><i>(Cited in Goyal et al. [2009], 84 year old woman developed mixed pattern of liver injury 56 days after starting clopidogrel, with resolution on follow up).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R13">Beltran-Robles M, Marquez Saavedra E, Sanchez-Mu&#x000f1;D, Romero-Gomez M. Hepatotoxicity induced by clopidogrel. J Hepatol 2004; 40: 560-2.  [<a href="/pubmed/15123377" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15123377</span></a>]<div><i>(59 year old man developed abnormal liver tests 4 days after starting clopidogrel [bilirubin 0.5 mg/dL, ALT 318 U/L, Alk P 100 U/L], resolving in 11 days of stopping and recurring within 4 days of restarting [ALT 119]).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R14">Chau TN, Yim KF, Mok NS, Chan WK, Leung VK, Leung MF, Lai ST. Clopidogrel-induced hepatotoxicity after percutaneous coronary stenting. Hong Kong Med J 2005; 11: 414-6.  [<a href="/pubmed/16219965" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16219965</span></a>]<div><i>(74 year old man developed jaundice 5 weeks after starting clopidogrel [bilirubin 5.3 mg/dL, ALT 212 U/L, Alk P 172 U/L], resolving within 4 weeks of stopping: Case 1).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R15">Ng JA, Goldberg N, Tafreshi MJ. Clopidogrel-induced hepatotoxicity and fever. Pharmacotherapy 2006; 26: 1023-6.  [<a href="/pubmed/16878371" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16878371</span></a>]<div><i>(59 year old woman developed fever 3 days after starting clopidogrel [bilirubin 1.5 mg/dL, ALT 536 U/L, Alk P 247 U/L, eosinophils 10%], fevers and laboratory abnormalities resolving with stopping, and recurring on restarting clopidogrel but then able to tolerate ticlopidine).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R16">H&#x000f6;llm&#x000fc;ller I, Stadlmann S, Graziadei I, Vogel W. Clinico-histopathological characteristics of clopidogrel-induced hepatic injury: case report and review of literature. Eur J Gastroenterol Hepatol 2006; 18: 931-4.  [<a href="/pubmed/16825915" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16825915</span></a>]<div><i>(80 year old man developed jaundice 6 weeks after starting clopidogrel [bilirubin 13.2 rising to 20.8 mg/dL, ALT 854 U/L, Alk P 221 U/L], resolving within 2 months of stopping).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R17">L&#x000f3;pez-Vicente J, Garfia C, L&#x000f3;pez-Medrano F, Yela C. [Hepatic toxicity and clopidogrel-induced systemic inflammatory response syndrome]. Rev Esp Cardiol 2007; 60: 323-4. Spanish.  [<a href="/pubmed/17394881" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17394881</span></a>]<div><i>(63 year old man developed fever and abdominal pain 4 weeks after starting clopidogrel [bilirubin 1.0 mg/dL, ALT 204, Alk P 682 U/L, eosinophils 3037/&#x000b5;L], resolving upon stopping clopidogrel).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R18">Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J; Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135: 1924-34.  [<a href="/pmc/articles/PMC3654244/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3654244</span></a>] [<a href="/pubmed/18955056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18955056</span></a>]<div><i>(Among 300 cases of drug induced liver disease in the US collected between 2004 and 2008, none were attributed to ticlopidine or clopidogrel).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R19">Wiper A, Schmitt M, Roberts DH. Clopidogrel-induced hepatotoxicity. J Postgrad Med 2008; 54: 152.  [<a href="/pubmed/18480537" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18480537</span></a>]<div><i>(56 year old man developed fatigue 2 months after starting clopidogrel [bilirubin normal, ALT ~450 U/L, Alk P ~680 U/L], resolving in 4 weeks but recurring upon restarting).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R20">Blombery PA, Russell PA, Daffy JR. An unusual case of recurrent fever, jaundice and right upper quadrant pain. Med J Aust 2009; 191: 396-7.  [<a href="/pubmed/19807633" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19807633</span></a>]<div><i>(66 year old man developed jaundice 2 months after starting clopidogrel [bilirubin 5.8 mg/dL, ALT 344 U/L, Alk P 357 U/L], with improvement on stopping and recurrence within a day of restarting clopidogrel [fever and jaundice], with biopsy showing granulomas, complete resolution 2 months after permanently stopping).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R21">Goyal RK, Srivastava D, Lessnau KD. Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: case report and review of the literature. Pharmacotherapy 2009; 29: 608-12.  [<a href="/pubmed/19397467" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19397467</span></a>]<div><i>(78 year old woman developed jaundice 2-3 weeks after starting clopidogrel [bilirubin 7.3 rising to 13 mg/dL, ALT 234 U/L, Alk P 1011 U/L], improving on stopping, and worsening on restarting clopidogrel and resolving upon permanent discontinuation; review of 12 published cases).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R22">Anselmino M, Moretti C, Ravera L, Sheiban I. Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting. Minerva Cardioangiol 2010; 58: 277-80.  [<a href="/pubmed/20440256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20440256</span></a>]<div><i>(81 year old woman developed jaundice 45 days after starting ticlopidine [details not given] and recovered after stopping; one year later clopidogrel was started without recurrence of liver injury).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R23">Kastalli S, El A&#x000ef;dli S, Za&#x000ef;em A, ben Abdallah H, Daghfous R. Fatal liver injury associated with clopidogrel. Fundam Clin Pharmacol 2010; 24: 433-5.  [<a href="/pubmed/19895648" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19895648</span></a>]<div><i>(63 year old man developed jaundice 19 days after starting clopidogrel which was continued until 54 days when he was admitted with ascites and jaundice [bilirubin 4.8 mg/dL, ALT 336 U/L, Alk P 186 U/L, prothrombin index 27%], developing progressive coma and dying 2 days later).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R24">Reuben A, Koch DG, Lee WM; Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010; 52: 2065-76.  [<a href="/pmc/articles/PMC3992250/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3992250</span></a>] [<a href="/pubmed/20949552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20949552</span></a>]<div><i> (Among 1198 patients with acute liver failure enrolled in a US prospective study between 1998 and 2007, 133 were attributed to drug induced liver injury, but none were due to clopidogrel or other antiplatelet medications).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R25">Leighton SP, Gordon C, Shand A. Clopidogrel, Turkey and a red herring? BMJ Case Rep 2011; 2011. pii: bcr0120113776. <a href="https://www.ncbi.nlm.nih.gov/pubmed/22700934" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>. [<a href="/pmc/articles/PMC3079450/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3079450</span></a>] [<a href="/pubmed/22700934" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22700934</span></a>]<div><i> (61 year old man with history of stroke and TIAs developed jaundice one month after starting clopidogrel [bilirubin 3.3 mg/dL, ALT 3636 U/L, Alk P 364 U/L] which improved after stopping clopidogrel, but was then found to be acute hepatitis E, probably acquired while traveling in Turkey).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R26">Monteiro PH, Dos Santos Pinheiro L, Alvoeiro L, Lucas M, Victorino RM. Clopidogrel-induced liver failure. JRSM Short Rep 2011; 2: 40. <a href="https://www.ncbi.nlm.nih.gov/pubmed/21637401" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>. [<a href="/pmc/articles/PMC3105452/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3105452</span></a>] [<a href="/pubmed/21637401" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21637401</span></a>]<div><i>(80 year old woman with diabetes and coronary artery disease developed nausea and dyspnea 1 month after starting clopidogrel [bilirubin 1.7 mg/dL, ALT 190 U/L, GGT 166 U/L, INR rising to 1.6] who worsened for a week, but then resolved within 1 month once clopidogrel was stopped).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R27">Pisapia R, Abdeddaim A, Mariano A, Rianda A, Vincenzi L, Taibi C, Baiocchini A, et al. Acute hepatitis associated with clopidogrel: a case report and review of the literature. Am J Ther 2015; 22: e8-e13.  [<a href="/pubmed/23846525" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23846525</span></a>]<div><i>(53 year old woman developed fatigue, rash followed by jaundice 3 months after starting atorvastatin and 2 days after starting clopidogrel [bilirubin 5 mg/dL, ALT 1603 U/L, Alk P 408 U/L, INR 1.14], and did not improve after stopping atorvastatin [bilirubin rising to 24.5, INR 1.8], but did after stopping clopidogrel).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R28">Zahno A, Bouitbir J, Maseneni S, Lindinger PW, Brecht K, Kr&#x000e4;henb&#x000fc;hl S. Hepatocellular toxicity of clopidogrel: Mechanisms and risk factors. Free Radic Biol Med 2013; 65C: 208-16.  [<a href="/pubmed/23770199" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23770199</span></a>]<div><i>(In vitro studies of clopidogrel effects on hepatocytes suggested that low cellular glutathione and high CYP 3A4 activity may predispose to hepatotoxicity). </i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R29">Bj&#x000f6;rnsson ES, Bergmann OM, Bj&#x000f6;rnsson HK, Kvaran RB, Olafsson S. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013; 144: 1419-25. <a href="https://www.ncbi.nlm.nih.gov/pubmed/23419359" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>. [<a href="/pubmed/23419359" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23419359</span></a>]<div><i>(In a population based study of drug induced liver injury from Iceland, 96 cases were identified over a 2 year period, but none were attributed to clopidogrel).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R30">Hern&#x000e1;ndez N, Bessone F, S&#x000e1;nchez A, di Pace M, Brahm J, Zapata R, A Chirino R, et al. Profile of idiosyncratic drug induced liver injury in Latin America: an analysis of published reports. Ann Hepatol 2014; 13: 231-9. <a href="https://www.ncbi.nlm.nih.gov/pubmed/24552865" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>. [<a href="/pubmed/24552865" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24552865</span></a>]<div><i>(Among 176 reports of drug induced liver injury from Latin America published between 1996 and 2012, none were attributed to clopidogrel).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R31">Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, et al.; United States Drug Induced Liver Injury Network. Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study. Gastroenterology 2015; 148: 1340-52.e7. <a href="https://www.ncbi.nlm.nih.gov/pubmed/25754159" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>. [<a href="/pmc/articles/PMC4446235/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4446235</span></a>] [<a href="/pubmed/25754159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25754159</span></a>]<div><i>(Among 899 cases of drug induced liver injury enrolled in a US prospective study between 2004 and 2013, none were due to clopidogrel).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R32">Kapila A, Chhabra L, Locke AD, Patel P, Khanna A, Reddy CM, Young MF. An idiosyncratic reaction to clopidogrel. Perm J 2015; 19: 74-6. <a href="https://www.ncbi.nlm.nih.gov/pubmed/25663208" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>. [<a href="/pmc/articles/PMC4315382/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4315382</span></a>] [<a href="/pubmed/25663208" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25663208</span></a>]<div><i> (75 year old woman developed fever 5 days after starting clopidogrel [bilirubin 1.6 mg/dL, ALT 716 U/L, Alk P 160 U/L], which resolved rapidly upon stopping and rechallenge resulted in rise in ALT [42 to 92 U/L] and AST [49 to 120 U/L] within two days).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R33">Keshmiri H, Behal A, Shroff S, Berkelhammer C. Clopidogrel-induced severe hepatitis: a case report and literature review. Case Reports Hepatol 2016; 2016: 8068276. <a href="https://www.ncbi.nlm.nih.gov/pubmed/27429813" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>. [<a href="/pmc/articles/PMC4939341/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4939341</span></a>] [<a href="/pubmed/27429813" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27429813</span></a>]<div><i>(34 year old man developed jaundice 4 months after starting clopidogrel [bilirubin 5.7 mg/dL, ALT 1393 U/L, Alk P 130 U/L, INR 1.5], worsening for a week and improving thereafter on a brief course of prednisone and ursodiol).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R34">Etxeberria Lekuona D, M&#x000e9;ndez L&#x000f3;pez I, Mercado MR, Oteiza J, Arteaga M, Jarne V. [Cholestasic toxic hepatitis due to clopidogrel in a patient with multiple conditions]. An Sist Sanit Navar 2016; 39: 143-8. <a href="https://www.ncbi.nlm.nih.gov/pubmed/27125614" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>. [<a href="/pubmed/27125614" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27125614</span></a>]<div><i> (78 year old man with diabetes and renal insufficiency developed metabolic acidosis and liver test abnormalities 4 months after starting clopidogrel [bilirubin 2.1 mg/dL, ALT 106 U/L, Alk P 1441 U/L], laboratory tests improving, but not completely upon stopping).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R35">Papagni S, Bonifati C, Dagostino F, Murgo AM. [Clopidogrel- induced hepatotoxicity in hemodialyzed patient: a case report]. G Ital Nefrol 2016; 33. pii: gin/33.1.7. Italian. <a href="https://www.ncbi.nlm.nih.gov/pubmed/26913747" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>. [<a href="/pubmed/26913747" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26913747</span></a>]<div><i>(71 year old diabetic on hemodialysis developed jaundice and ascites shortly after starting clopidogrel, which improved slowly upon stopping).</i></div></div></li><li><div class="bk_ref" id="Clopidogrel.R36">Drug interaction: Clopidogrel and PPIs. Med Lett Drugs Ther 2017; 59 (1515): 39-40. <a href="https://www.ncbi.nlm.nih.gov/pubmed/28222065" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>. [<a href="/pubmed/28222065" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28222065</span></a>]<div><i> (Concurrent use of clopidogrel and omeprazole may decrease the antiplatelet activity, but the clinical significance of the effect has not been shown).</i></div></div></li></ul></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK547946</span><span class="label">PMID: <a href="/pubmed/31643279" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31643279</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Clonidine/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Clorazepate/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK547946&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK547946/?report=reader">PubReader</a></li><li><a href="/books/NBK547946/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK547946" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK547946" style="display:none" title="Cite this Page"><div class="bk_tt">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.  Clopidogrel. [Updated 2017 Oct 17].<span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK547946/pdf/Bookshelf_NBK547946.pdf">PDF version of this page</a> (124K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Bulk Download</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://ftp.ncbi.nlm.nih.gov/pub/litarch/29/31/" ref="pagearea=source-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Bulk download LiverTox data from FTP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Overviews</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/intro/">Introduction</a></li><li><a href="/books/n/livertox/Causality/">Causality</a></li><li><a href="/books/n/livertox/ClinicalCourse/">Clinical Course</a></li><li><a href="/books/n/livertox/ClinicalOutcome/">Clinical Outcomes</a></li><li><a href="/books/n/livertox/ImmuneFeatures/">Immune Features</a></li><li><a href="/books/n/livertox/DrugCategory/">Likelihood Scale</a></li><li><a href="/books/n/livertox/Phenotypes_intro/">Phenotypes</a></li><li><a href="/books/n/livertox/Severity/">Severity Grading</a></li><li><a href="/books/n/livertox/CaseReport/">Writing a Case Report</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Support Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/">LiverTox Homepage</a></li><li><a href="/books/n/livertox/aboutus/">About LiverTox</a></li><li><a href="/books/n/livertox/editorsandreviewers/">Editors and Review Committee</a></li><li><a href="/books/n/livertox/alert/">Meetings and News</a></li><li><a href="/books/n/livertox/abbreviation/">Abbreviations Used</a></li><li><a href="/books/n/livertox/glossary/">Glossary</a></li><li><a href="/books/n/livertox/resource/">Information Resources</a></li><li><a href="/books/n/livertox/disclaimer/">User/Medical Advice Disclaimer</a></li><li><a href="/books/n/livertox/Contactus/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>OTHER REFERENCE LINKS</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;pubmedfilters=true&amp;term=(Clopidogrel/AE)+AND+Human%5BMH%5D+AND+(drug+induced+liver+injury+OR+jaundice/CI+OR+bile+duct+diseases/CI+OR+liver/DE+OR+liver+diseases/CI)+AND+(%221900/1/1%22%5BEDat%5D%3A%222999/12/31%22%5BEDat%5D)" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Recent References on Clopidogrel: from PubMed.gov</a></li><li><a href="https://clinicaltrials.gov/ct2/results?term=Clopidogrel" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Trials on Clopidogrel: from ClinicalTrials.gov</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4865640" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pcsubstance&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pcsubstance&amp;IdsFromResult=4865640" ref="log$=recordlinks">PubChem Substance</a><div class="brieflinkpop offscreen_noflow">Related PubChem Substances</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4865640" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31643369" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ticlopidine</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ticlopidine<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24359966" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.</a><span class="source">[Thromb Res. 2014]</span><div class="brieflinkpop offscreen_noflow">High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Leé S, Vargová K, Hizoh I, Horváth Z, Gulácsi-Bárdos P, Sztupinszki Z, Apró A, Kovács A, Préda I, Tóth-Zsámboki E, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Thromb Res. 2014 Feb; 133(2):257-64. Epub 2013 Dec 6.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/18721506" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction.</a><span class="source">[Am J Cardiol. 2008]</span><div class="brieflinkpop offscreen_noflow">Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Matetzky S, Fefer P, Shenkman B, Varon D, Savion N, Hod H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Cardiol. 2008 Sep 1; 102(5):524-9. Epub 2008 Jun 12.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25199965" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Time-related changes in determinants of antiplatelet effect of clopidogrel in patients after myocardial infarction.</a><span class="source">[Eur J Pharmacol. 2014]</span><div class="brieflinkpop offscreen_noflow">Time-related changes in determinants of antiplatelet effect of clopidogrel in patients after myocardial infarction.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kubica A, Kasprzak M, Siller-Matula J, Koziński M, Pio Navarese E, Obońska K, Andruszkiewicz A, Sztuba B, Fabiszak T, Swiątkiewicz I, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Pharmacol. 2014 Nov 5; 742:47-54. Epub 2014 Sep 6.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/10473907" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clopidogrel for cerebrovascular prevention.</a><span class="source">[Cerebrovasc Dis. 1999]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clopidogrel for cerebrovascular prevention.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Paciaroni M, Bogousslavsky J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cerebrovasc Dis. 1999 Sep-Oct; 9(5):253-60. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31643279" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31643279" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="&#10;                        HTOn&#10;                    "><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2021-03-08T14:37:45-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@9.2&amp;Host=portal106&amp;ncbi_phid=CE8D1B74046641D100000000056401AD&amp;ncbi_session=CE8D1B740467D071_1380SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK547946%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK547946&amp;ncbi_domain=livertox&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK547946/&amp;ncbi_pagename=Clopidogrel - LiverTox - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D1B740467D071_1380SID /projects/books/PBooks@9.2 portal106 v4.1.r621975 Fri, Dec 18 2020 02:56:50 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>